Thursday, August 20, 2020

RACE Act to Boost Innovation in Pediatric Cancer Research

Formerly named the best small-sized healthcare company CFO, Mark Hirschhorn serves as the president and COO of teletherapy company Talkspace. Mark Hirschhorn has also contributed to numerous health-related nonprofit organizations, including the Pediatric Cancer Foundation (PCF).

According to the PCF, less than 4 percent of dedicated federal funding goes toward pediatric cancer research. To improve this number, the Research to Accelerate Cures and Equity (RACE) for Children Act was passed in 2017. As of early August 2020, companies that develop therapies and drugs for adult cancers must also investigate the treatments’ effectiveness and safety for children.

Before this legislation, many cancer drug companies would bypass clinical trials for pediatric cancers because of a combination of a smaller market and clinical trials for children. The RACE Act limits the drugs exempted from this extra research. The act will spur more innovation in pediatric cancer treatment, which historically has lagged behind advances in the treatment of adult cancers.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.